Chronic kidney disease: The distribution of health care dollars

Kidney International

Volumn 66, Issue 1, 2004, Pages 313-321

  St Peter, Wendy L ^a   Khan, Samina S ^b   Ebben, James P ^b   Pereira, Brian J G ^b   Collins, Allan J ^b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b NONE

Author keywords

Chronic kidney disease; Cost; Expenditures; Medicare allowable; Medicare Part A; Medicare Part B

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; DIABETES MELLITUS; DIALYSIS; FEMALE; HEALTH CARE COST; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 3042728473     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00733.x     Document Type: Article

References (43)

1. SMITH S, FREELAND M, HEFFLER S, MCKUSICK D: The next ten years of health spending: what does the future hold? The Health Expenditures Projection Team. Health Aff (Millwood) 17:128-140, 1998
2. U.S. RENAL DATA SYSTEM: USRDS 2003 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
3. XUE JL, MA JZ, LOUIS TA, COLLINS AJ: Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 12:2753-2758, 2001
4. U.S. RENAL DATA SYSTEM: USRDS 2002 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
5. NATIONAL KIDNEY FOUNDATION: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39(Suppl 1):S1-S266, 2002
6. LONDON R, SOLIS A, GOLDBERG GA, et al: Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis 40:539-548, 2002
7. ROBBINS JD, KIM JJ, ZDON G, et al: Resource use and patient care associated with chronic kidney disease in a managed care setting. J Manag Care Pharm 9:238-247, 2003
8. U.S. RENAL DATA SYSTEM: USRDS 2001 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001
9. HEBERT PL, GEISS LS, TIERNEY EF, et al: Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14:270-277, 1999
10. SEHGAL AR, DOR A, TSAI AC: Morbidity and cost implications of inadequate hemodialysis. Am J Kidney Dis 37:1223-1231, 2001
11. LEE H, MANNS B, TAUB K, et al: Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611-622, 2002
12. NISSENSON AR, COLLINS AJ, HURLEY J, et al: Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol 12:1713-1720, 2001
13. BRUNS FJ, SEDDON P, SAUL M, ZEIDEL ML: The cost of caring for end-stage kidney disease patients: An analysis based on hospital financial transaction records. J Am Soc Nephrol 9:884-890, 1998
14. ARORA P, KAUSZ AT, OBRADOR GT, et al: Hospital utilization among chronic dialysis patients. J Am Soc Nephrol 11:740-746, 2000
15. HOLLAND DC, LAM M: Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study. Nephrol Dial Transplant 15:650-658, 2000
16. KHAN SS, KAZMI WH, ABICHANDANI R, et al: Health care utilization among patients with chronic kidney disease. Kidney Int 62:229-236, 2002
17. ST PETER WL, SCHOOLWERTH AC, MCGOWAN T, MCCLELLAN WM: Chronic kidney disease: Issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 41:903-924, 2003
18. MIX TC, ST PETER WL, EBBEN J, et al: Hospitalization during advancing chronic kidney disease. Am J Kidney Dis 42:972-981, 2003
19. NKF-DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30:S150-S191, 1997
20. OBRADOR GT, PEREIRA BJ: Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 31:398-417, 1998
21. U.S. RENAL DATA SYSTEM: USRDS 1997 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997
22. PISONI RL, YOUNG EW, DYKSTRA DM, et al: Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 61:305-316, 2002
23. DHINGRA RK, YOUNG EW, HULBERT-SHEARON TE, et al: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60:1443-1451, 2001
24. STACK AG: Determinants of modality selection among incident US dialysis patients: Results from a national study. J Am Soc Nephrol 13:1279-1287, 2002
25. MISKULIN DC, MEYER KB, ATHIENITES NV, et al: Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 39:324-336, 2002
26. DIMKOVIC N, OREOPOULOS DG: Chronic peritoneal dialysis in the elderly. Semin Dial 15:94-97, 2002
27. SHLIPAK MG, FRIED LF, CRUMP C, et al: Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 62:997-1004, 2002
28. CULLETON BF, LARSON MG, WILSON PWF, et al: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999
29. CULLETON BF, LARSON MG, EVANS JC, et al: Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study. Arch Intern Med 159:1785-1790, 1999
30. LEVIN A, SINGER J, THOMPSON CR, et al: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996
31. NATIONAL KIDNEY FOUNDATION: Clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41:S8-S91, 2003
32. LEVIN A, THOMPSON CR, ETHIER J, et al: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34:125-134, 1999
33. XUE JL, ST. PETER WL, EBBEN JP, et al: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40:1153-1161, 2002
34. FINK J, BLAHUT S, REDDY M, LIGHT P: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37:348-355, 2001
35. JUNGERS P, MASSY ZA, NGUYEN-KHOA T, et al: Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 16:2357-2364, 2001
36. MISKULIN DC, MEYER KB, MARTIN AA, et al: Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis 41:149-161, 2003
37. MA J, EBBEN J, XIA H, COLLINS A: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10:610-619, 1999
38. COLLINS AJ, LI S, ST. PETER WL, et al: Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 12:2465-2473, 2001
39. COLLINS AJ, LI S, EBBEN J, et al: Hematocrit levels and associated Medicare expenditures. Am J Kidney Dis 36:282-293, 2000
40. ANSARI Z, HABY MM, HENDERSON T, et al: Trends and geographic variations in hospital admissions for asthma in Victoria. Opportunities for targeted interventions. Aust Fam Physician 32:286-288, 2003
41. TU JV, GONG Y: Trends in treatment and outcomes for acute stroke patients in Ontario, 1992-1998. Arch Intern Med 163:293-297, 2003
42. ANSARI M, ALEXANDER M, TUTAR A, et al: Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol 41:62-68, 2003
43. COLLINS AJ, LI S, GILBERTSON DT, et al: Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 64 (Suppl 87):S24-S31, 2003